Overall rank by patents
#24,552
Across all tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 17 technology areas, active 2020–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
The verdict
Indorma holds 11 US patents across 17 technology areas, rank #24,552 of 50,000 tracked assignees.
Indorma Ventures Oxides Llc has been granted 11 US utility patents between 2020 and 2024, placing Indorma Ventures Oxides Llc at rank #24,552 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 14.1 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a US Corporation, Indorma Ventures Oxides Llc is one of the more focused assignees in the PatentsView dataset. By volume, Indorma sits between Imagescan, Inc. (11 patents, rank #24,548) and Inhibrx Biosciences, Inc. (11 patents, rank #24,556) - the closest US assignees by grant volume. The composite Innovation Score of 37.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2020 through 2024, with 11 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Indorma Ventures Oxides Llc's 14.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 17 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Indorma Ventures Oxides Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
ImageScan, Inc.
11 patents
Imago Biosciences, Inc.
11 patents
InCarda Therapeutics, Inc.
11 patents
Indian Ocean Medical Inc.
11 patents
Industrilås i Nässjö Aktiebolag
11 patents
Infinitum Solutions, Inc.
11 patents
Information Resources, Inc.
11 patents
Inhibrx Biosciences, Inc.
11 patents
Indorma Ventures Oxides LLC
11 patents
What this shows Indorma holds 11 patents at rank #24,552, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Indorma's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
37 Top 44% higher than 56% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 2 | 18.2% |
| 2021 | 4 | 36.4% |
| 2022 | 3 | 27.3% |
| 2023 | 1 | 9.1% |
| 2024 | 1 | 9.1% |
Top 15 of 17 technology areas
Overall rank by patents
#24,552
Across all tracked assignees
37.2 out of 100
How to use this portfolio
Indorma's 11 grants land it in the top 44% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.